Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain

Virology

Volumn 288, Issue 2, 2001, Pages 223-235

  Danve, Christelle ^a   Decaussin, Gisèle ^a   Busson, Pierre ^b   Ooka, Tadamasa ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL AGING; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA TRANSFECTION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; MONKEY; NASOPHARYNX CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STOMACH CARCINOMA; VIRUS GENE; VIRUS PARTICLE; VIRUS STRAIN;

EID: 0035975601     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1072     Document Type: Article

References (45)

1. Variation in sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphoma
2. Characterization of an Epstein-Barr virus receptor on human epithelial cells
3. Normal keratinization in a spontaneously immortalized aneuploid keratinocyte cell line
4. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1 and LMP2 transcripts
5. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas
6. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
7. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene
8. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells
9. Individual tumours of multifocal EB virus-induced malignant lymphoma in tamarins arise from different B-Cell clones
10. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells
11. The lytic cycle of Epstein-Barr virus in non-producer Raji line can be rescued by the expression of e 135 kDa protein encoded by BALF2 ORF deleted in the cells
12. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies
13. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma
14. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor
15. The oncogenic potential of herpes simplex viruses: Evidence for a "hit and run" mechanism
16. Epithelial cell polarization is a determinant in the infections outcome of immunoglobulin A-mediated entry by Epstein-Barr virus
17. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for a viral protein expressed in vivo
18. Immunofluorescence in cells derived from Burkitt's lymphoma
19. EBV gene expression in an NPC-related tumor
20. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection in diverse human epithelial cells
21. Epstein-Barr virus and its replication
22. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx
23. In vitro production of stable Epstein-Barr cell clones which ressemble the virus: Cell interaction observed in NRC
24. Epstein-Barr virus infection and replication in a human epithelial cell
25. Detection of antigens associated with Epstein-Barr virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas
26. Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression
27. Effects of arabinofuranosylthymine on Epstein-Barr virus replication
28. Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity
29. Epstein-Barr virus and gastric carcinoma
30. Cellular localization of Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines
31. Expression of EBV DNAase in the tumour cells of nasopharyngeal carcinoma
32. Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in Algerian nasopharyngeal carcinoma
33. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant pheno-types of BL cells are dependent on EBV
34. Replication of Epstein-Barr virus in human epithelial cells infected in vitro
35. Epstein-Barr virus protein BARF1 expressed in lymphoid cell lines serves as a target for antibody-dependant cellular cytotoxicity
36. Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines established from tumor biopsies
37. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
38. Expression of the BARF1 gene encoded by Epstein-Barr virus in human lymphoid cells and its tumorigenicity
39. A transforming function of the BARF 1 gene encoded by Epstein-Barr virus
40. Establishment of a monkey kidney epithelial cell line with the Epstein-Barr virus BARF1 gene
41. Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21
42. Epstein-Barr virus gene expression in nasopharyngeal carcinoma
43. Transcriptional expression of the viral genome in the Epstein-Barr virus induced tamarin lymphoma and the corresponding lymphioblastoid tumour lines
44. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: Expression of the transforming BARF1 gene
45. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinoma of the nasopharynx